Home > ETX0282

molecules of the month

<< Back to July

ETX0282

Recent Publication

oral prodrug of serine _-lactamase inh.

in dev. for multidrug resistant bact. infection

from optimization of prior _-lactamase inh.

J. Med. Chem., Jul. 24, 2020

Entasis Therapeutics, Waltham, MA

ETX0282 is an oral prodrug of a class A, C, and D serine β-lactamase inhibitor in clinical development for drug-resistant enterobacterial infections in combination with the beta-lactam drug cefpodoxime proxetil.…

this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.

LEARN MORE

ETX0282

this content is exclusive to Premium members

this content is exclusive to
Premium members